SG11201706316PA - Method of preventing or treating hearing loss - Google Patents

Method of preventing or treating hearing loss

Info

Publication number
SG11201706316PA
SG11201706316PA SG11201706316PA SG11201706316PA SG11201706316PA SG 11201706316P A SG11201706316P A SG 11201706316PA SG 11201706316P A SG11201706316P A SG 11201706316PA SG 11201706316P A SG11201706316P A SG 11201706316PA SG 11201706316P A SG11201706316P A SG 11201706316PA
Authority
SG
Singapore
Prior art keywords
preventing
hearing loss
treating hearing
treating
loss
Prior art date
Application number
SG11201706316PA
Inventor
Alexander Bausch
Original Assignee
Support-Venture Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Support-Venture Gmbh filed Critical Support-Venture Gmbh
Publication of SG11201706316PA publication Critical patent/SG11201706316PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SG11201706316PA 2015-02-11 2016-02-10 Method of preventing or treating hearing loss SG11201706316PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15154764 2015-02-11
PCT/EP2016/052787 WO2016128438A1 (en) 2015-02-11 2016-02-10 Method of preventing or treating hearing loss

Publications (1)

Publication Number Publication Date
SG11201706316PA true SG11201706316PA (en) 2017-09-28

Family

ID=52573594

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201706316PA SG11201706316PA (en) 2015-02-11 2016-02-10 Method of preventing or treating hearing loss

Country Status (20)

Country Link
US (1) US20180021320A1 (en)
EP (1) EP3256127A1 (en)
JP (1) JP2018505222A (en)
KR (1) KR20170117083A (en)
CN (1) CN107205995A (en)
AU (1) AU2016217937A1 (en)
BR (1) BR112017016909A2 (en)
CA (1) CA2975566A1 (en)
CL (1) CL2017002021A1 (en)
CO (1) CO2017008129A2 (en)
EA (1) EA201791538A1 (en)
HK (1) HK1245657A1 (en)
IL (1) IL253783A0 (en)
MA (1) MA41490A (en)
MX (1) MX2017010092A (en)
PE (1) PE20171619A1 (en)
PH (1) PH12017550064A1 (en)
SG (1) SG11201706316PA (en)
WO (1) WO2016128438A1 (en)
ZA (1) ZA201705997B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689027A (en) 2016-06-29 2019-04-26 奥德纳米有限公司 Triglycerides aural preparations and application thereof
CN109562105A (en) * 2016-08-17 2019-04-02 企业支持有限责任公司 The method of prevention or treatment hearing loss
WO2019154895A1 (en) * 2018-02-08 2019-08-15 Strekin Ag Gel formulation for preventing or treating hearing loss
WO2019154893A1 (en) * 2018-02-08 2019-08-15 Strekin Ag Oral extended release pharmaceutical compositions for preventing or treating hearing loss
CN108403628B (en) * 2018-05-21 2021-01-08 北京和舆医药科技有限公司 Dexamethasone sodium phosphate injection
CN109498648A (en) * 2018-12-26 2019-03-22 中山大学附属第三医院（中山大学肝脏病医院） A kind of model of combination formulations and its building for constructing mouse cis-platinum cochlea damage model
WO2022140636A1 (en) * 2020-12-22 2022-06-30 Otonomy, Inc. Gacyclidine otic formulations and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040171692A1 (en) * 2003-02-28 2004-09-02 Scutt Andrew Modulation of bone formation
JP2010531138A (en) * 2007-06-13 2010-09-24 ラ ホヤ インスティテュート フォア アラージー アンド イムノロジー Regulatory T cells and methods of production and use thereof

Also Published As

Publication number Publication date
PH12017550064A1 (en) 2018-02-05
MA41490A (en) 2021-04-07
BR112017016909A2 (en) 2018-03-27
AU2016217937A1 (en) 2017-08-24
CN107205995A (en) 2017-09-26
CL2017002021A1 (en) 2018-06-01
CA2975566A1 (en) 2016-08-18
EP3256127A1 (en) 2017-12-20
ZA201705997B (en) 2019-07-31
CO2017008129A2 (en) 2017-11-10
WO2016128438A1 (en) 2016-08-18
HK1245657A1 (en) 2018-08-31
KR20170117083A (en) 2017-10-20
JP2018505222A (en) 2018-02-22
MX2017010092A (en) 2018-06-06
EA201791538A1 (en) 2018-01-31
PE20171619A1 (en) 2017-11-02
IL253783A0 (en) 2017-09-28
US20180021320A1 (en) 2018-01-25

Similar Documents

Publication Publication Date Title
HK1248552A1 (en) Method of treatment with tradipitant
HK1245657A1 (en) Method of preventing or treating hearing loss
ZA201903873B (en) Methods of treating cochlear synaptopathy
HK1252692A1 (en) Methods of treating or preventing a proteopathy
HK1249515A1 (en) Methods and compositions for the prevention and treatment of hearing loss
GB2567616B (en) Treatment method
IL272092A (en) Methods of treating behavior alterations
IL267199A (en) Method of treating epilepsy
GB201904142D0 (en) Improved method of FT-IMS
GB201706406D0 (en) Method of treatment
GB2571601B (en) Treatment method
GB201815588D0 (en) Method of treatment
SG11202001806TA (en) Treatment method
EP3491129A4 (en) Methods of treating osmidrosis
EP3490547A4 (en) Method of treatment
GB201602802D0 (en) Method of treatment
EP3368037A4 (en) Novel methods of treating hearing loss
IL264625A (en) Method of preventing or treating hearing loss
IL270867A (en) Treatment method
EP3148523A4 (en) Method of inhibiting or treating fibrosis
GB201720439D0 (en) Method of treatment
GB201718589D0 (en) Method of treatment
GB201709554D0 (en) Method of treatment
GB201706642D0 (en) Method of treatment
GB201706452D0 (en) Method of treatment